Senores Pharmaceuticals Ltd (SENORES) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 10039497, "name": "Senores Pharma.", "stock_name": "Senores Pharma.", "full_name": "Senores Pharmaceuticals Ltd", "name_url": "stocks-analysis/senores-pharma", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "1,140.70", "chg": 29.75, "chgp": "2.68%", "dir": 1, "prev_price": "1,110.95", "mcapval": "5,253.33 Cr", "mcap": "Small Cap", "scripcode": "544319", "symbol": "SENORES", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE0RB801010", "curr_date": "May 25", "curr_time": "", "bse_nse_vol": "2.45 lacs", "exc_status": "Active", "traded_date": "May 25, 2026", "traded_date_str": "2026 05 25", "score": "", "scoreText": "", "Live": 0, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/senores-pharma-10039497-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Senores Pharmaceuticals Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/senores-pharmaceuticals-ltd-is-rated-buy-4007992", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_mojoScore_4007992.png", "date": "2026-05-23 10:10:05", "description": "Senores Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 08 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 May 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Senores Pharmaceuticals Gains 5.52%: 4 Key Factors Driving the Week’s Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-gains-552-4-key-factors-driving-the-weeks-momentum-4007677", "imagepath": "", "date": "2026-05-23 10:00:05", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>18 May:</strong> New 52-week and all-time highs reached (Rs.1,130.05)</p>\n <p><strong>19 May:</strong> Valuation shifts to very expensive amid strong price surge</p>\n <p><strong>20 May:</strong> Moderate recovery after correction (Rs.1,082.95)</p>\n <p><strong>21 May:</strong> Continued gains supported by technical strength (Rs.1,107.70)</p>\n <p><strong>22 May:</strong> Week closes near highs at Rs.1,110.45 (+0.25%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,052.35</div></d..." }, { "title": "Senores Pharmaceuticals Ltd Valuation Shifts Amid Strong Market Performance", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-valuation-shifts-amid-strong-market-performance-3997953", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_valuationdot_3997953.png", "date": "2026-05-19 08:03:11", "description": "Senores Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive classification, despite robust stock price gains and strong operational metrics. This article analyses the evolving price attractiveness of the small-cap pharmaceutical player in the context of its peer group and historical benchmarks." }, { "title": "Senores Pharmaceuticals Ltd Surges 7.87% to Day's High of Rs 1130 — Outperforms Sector by 8.06 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-hits-intraday-high-with-strong-787-surge-3996950", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_priceRelatedfactors_3996950.png", "date": "2026-05-18 11:01:09", "description": "While the Sensex retreated 0.76% on 18 May 2026, Senores Pharmaceuticals Ltd surged 7.87%, touching a fresh 52-week and all-time high of Rs 1130. This 8.06 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a market-wide uplift." }, { "title": "Broad-Based Technical Strength Lifts Senores Pharmaceuticals Ltd to 52-Week High of Rs 1099.2", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-hits-new-52-week-high-at-rs10992-3996442", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_priceRelatedfactors_3996442.png", "date": "2026-05-18 09:44:49", "description": "Surging to an all-time high of Rs 1099.2 on 18 May 2026, Senores Pharmaceuticals Ltd has demonstrated remarkable price momentum, outpacing its sector and the broader market with a 122.94% gain over the past year. This milestone caps a sustained rally fuelled by a confluence of bullish technical indicators and robust trading volumes, even as the Sensex languishes near its 52-week lows." }, { "title": "Senores Pharmaceuticals Ltd Hits All-Time High of Rs 1,091.45 as Momentum Builds Across Timeframes", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-hits-all-time-high-at-rs-109145-3996378", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_priceRelatedfactors_3996378.png", "date": "2026-05-18 09:33:47", "description": "Extending its recent rally, Senores Pharmaceuticals Ltd surged to a fresh all-time high of Rs 1,091.45 on 18 May 2026, outperforming its sector and the broader market with a 4.20% gain on the day." }, { "title": "Senores Pharmaceuticals Surges 8.88%: 5 Key Drivers Behind the Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-surges-888-5-key-drivers-behind-the-rally-3993743", "imagepath": "", "date": "2026-05-16 09:07:03", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>11 May:</strong> New 52-week and all-time highs near Rs.980</p>\n <p><strong>13 May:</strong> Stock rebounds with 5.10% gain, hits Rs.985 high</p>\n <p><strong>14 May:</strong> Breaks Rs.1,000 mark, new 52-week high at Rs.1,006.95</p>\n <p><strong>15 May:</strong> Intraday surge to Rs.1,020.9, closes at Rs.1,052.35 (+10.22%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.966.55</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,..." }, { "title": "Are Senores Pharmaceuticals Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-senores-pharmaceuticals-ltd-latest-results-good-or-bad-3993382", "imagepath": "", "date": "2026-05-15 19:29:20", "description": "Senores Pharmaceuticals Ltd has reported its financial results for Q4 FY26, highlighting a significant year-on-year growth in net profit and net sales. The company achieved a net profit of ₹31.61 crores, reflecting a 77.29% increase compared to the same quarter last year. Additionally, net sales reached ₹175.19 crores, marking a robust year-on-year growth of 53.39%. This performance underscores the company's strong revenue growth trajectory, with seven consecutive quarters of sequential revenue increases.\n\nHowever, the operational metrics reveal some challenges. The operating margin, excluding other income, contracted to 27.11% from 29.48% in the previous quarter, indicating pressure on profitability. This sequential decline raises questions about the sustainability of the company's pricing power and cost management as it continues to expand. Furthermore, while the profit after tax (PAT) margin improved to ..." }, { "title": "Senores Pharmaceuticals Ltd Surges 7.36% to Day's High of Rs 1020.9 — Outperforms Sector by 6.41 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-hits-intraday-high-with-736-surge-on-15-may-2026-3992867", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_priceRelatedfactors_3992867.png", "date": "2026-05-15 13:45:59", "description": "The Sensex edged up 0.2% on 15 May 2026, while Senores Pharmaceuticals Ltd surged 7.36%, touching a new 52-week and all-time high of Rs 1020.9. This 6.41 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a broad market lift." } ], "total": 237, "sid": "10039497", "stock_news_url": "https://www.marketsmojo.com/news/senores-pharmaceuticals-10039497" }, "announcements": "", "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

11 May: New 52-week and all-time highs near Rs.980

13 May: Stock rebounds with 5.10% gain, hits Rs.985 high

14 May: Breaks Rs.1,000 mark, new 52-week high at Rs.1,006.95

15 May: Intraday surge to Rs.1,020.9, closes at Rs.1,052.35 (+10.22%)

Read full news article

Are Senores Pharmaceuticals Ltd latest results good or bad?

2026-05-15 19:29:20

Senores Pharmaceuticals Ltd has reported its financial results for Q4 FY26, highlighting a significant year-on-year growth in net profit and net sales. The company achieved a net profit of ₹31.61 crores, reflecting a 77.29% increase compared to the same quarter last year. Additionally, net sales reached ₹175.19 crores, marking a robust year-on-year growth of 53.39%. This performance underscores the company's strong revenue growth trajectory, with seven consecutive quarters of sequential revenue increases. However, the operational metrics reveal some challenges. The operating margin, excluding other income, contracted to 27.11% from 29.48% in the previous quarter, indicating pressure on profitability. This sequential decline raises questions about the sustainability of the company's pricing power and cost management as it continues to expand. Furthermore, while the profit after tax (PAT) margin improved to ...

Read full news article

Senores Pharmaceuticals Ltd Surges 7.36% to Day's High of Rs 1020.9 — Outperforms Sector by 6.41 Percentage Points

2026-05-15 13:45:59

The Sensex edged up 0.2% on 15 May 2026, while Senores Pharmaceuticals Ltd surged 7.36%, touching a new 52-week and all-time high of Rs 1020.9. This 6.41 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a broad market lift.

Read full news article